¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycogen storage disease type III"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 6
¿µ¹® Paget's disease ÇÑ±Û ÆÄÁ¦Æ®º´
¼³¸í   
  1. »ÀÆÄÁ¦Æ®º´. º¯Çü¼º »À¿°. »ÀÈí¼ö ÈÄ »ÀÇü¼ºÀÌ ¹Ýº¹ÀûÀ¸·Î °úµµÇϰԠÀϾ´Â °ÍÀ¸·Î, »õ·Ó°Ô Çü¼ºµÈ »À´Â ¹«Áú¼­Ç졒ʱ¸Á¶ÀûÀ¸·Î °ß°íÇÏÁö ¸øÇÏ´Ù. »ÀÈí¼öÀÇ Áõ°¡°¡ ¹Ýº¹µÇ°í À̾ °úÀ׺¸¼ö¸¦ ²ÒÇÏ¿© ¾àÇ졒ʼ¯ÇüµÈ »ÀÀÇ ºÎÇǰ¡ Áõ°¡µÇ´Â °ÍÀ» Æ¯Â¡À¸·Î Çϴ »Àº´ÀÌ´Ù. ±ÃµÕ»ÀÀÇ ¸¸°î, ÆíÆò»ÀÀÇ º¯ÇüÀ» ÀÏÀ¸Å°°í, µ¿Åë ¹× º´Àû °ñÀýÀ» ¼ö¹ÝÇÑ´Ù. 2. À¯¹æÆÄÁ¦Æ®º´. Á¥²ÉÆÇ ¹× Á¥²ÀÁöÀÇ ¿°Áõ¼º ¾Ï¼º Áúº´À¸·Î¼­ º¸ÅëÀº Á¥»ù ¹× À¯¹æ ±íÀº °÷ÀÇ ¾ÏÀ» µ¿¹ÝÇÑ´Ù. º¸Åë Áß³âºÎÀο¡°Ô ¹ß»ýÇÑ´Ù.
¿µ¹® Parkinson disease ÇÑ±Û ÆÄŲ½¼º´
¼³¸í   
  ³ªÀ̵砻ç¶÷¿¡°Ô ¹ß»ýÇϴ ½Å°æ°èÀÇ ÅðÇິÀÌ´Ù. ÁַΠ¿îµ¿À» ´ã´çÇϴ Áß°£³úºÎÀ§°¡ Ä§¹üµÈ´Ù. ¿øÀÎÀº ¹ÙÀÌ·¯½º, ¾à¹°, È¤Àº µ¿¸Æ°æÈ­Áõ µîÀ¸·Î ¾Ë·ÁÁø °æ¿ìµµ ÀÖÀ¸³ª, ¿øÀÎÀ» ¾Ë ¼ö ¾ø´Â °æ¿ì°¡ ¸¹´Ù. Áõ»óÀº °¡¸é¾ó±¼, ¾²·¯Áú °Í °°Àº °ÉÀ½°ÉÀÌ, ¼Õ¶³¸², ±ÙÀ°ÀÇ °­Á÷, ¾ÕÀ¸·Î ±â¿ï¾îÁø ÀÚ¼¼ µîÀÓ. Ä¡·á´Â Æ¯º°ÇÑ °ÍÀÌ ¾øÀ¸¸ç, ´ë°³ º¸Á¸Àû Ä¡·á(¿ÏÄ¡¸¦ ¸ñÀûÀ¸·Î ÇÏÁö ¾Ê°í ´ÜÁö È¯ÀÚÀÇ »ýȰÀ» º¸Á¶ÇØÁִ Á¤µµÀÇ Ä¡·á)¸¦ ½ÃÇàÇÑ´Ù. ÃÖ±Ù, Á×Àº Å¾ÆÀÇ ³ú¸¦ À̽ÄÇϴ ³ú À̽ļú¿¡ ÀÇÇÑ Ä¡·áÈ¿°ú°¡ ³ô´Ù´Â º¸°í°¡ ÀÖ´Ù.
¿µ¹® endemic disease ÇÑ±Û Ç³Å亴
¼³¸í   
  Àΰ£»çȸ¿¡ Ç×»ó Á¸ÀçÇÏÁö¸¸ Æ¯¼öÇÑ ±âÈijª ÅäÁú·Î ÀÎÇÏ¿© Æ¯Á¤Áö¿ª¿¡¸¸ Á¸ÀçÇϴ »ç¸Á·üÀÌ ³·°í, ÀÓ»óÀûÀ¸·Îµµ µå¹°°Ô º¼ ¼ö Àִ º´. Æ¯È÷ ±× ÅäÁöÀǠdzÅä-±âÈÄ-»ý¹°-Åä¾ç µîÀÇ ÀÚ¿¬È¯°æ°ú ±× Áö¹æ ÁÖ¹ÎÀǠdz¼Ó-½À°ü-ÀνÀ µîÀÌ º¹ÀâÇϰԠ¾ôÇô¼­ »ý±ä Æ¯¼öÇÑ º´À» °¡¸®Å²´Ù. ÀϹÝÀûÀ¸·Î ±× Áö¹æ ÁÖ¹ÎÀÇ »ç¸Á·üÀº ±×´ÙÁö ³ôÁö ¾ÊÁö¸¸ ±ÙÀýµÇ±â ¾î·Á¿î °ÍÀ̠Ư¡ÀÌ´Ù. Áö¹æº´À̶ó´Â ¸»Àº ¾î´À Áö¹æ¿¡ ÇÑÁ¤ÇÏ¿© º¼ ¼ö Àִ º´À̶ó´Â Á¡¿¡¼­´Â °°Áö¸¸, Ç³Åäȯ°æ°ú ¹ÐÁ¢ÇÑ °ü°è°¡ Àִٴ µ¥¼­ º¸¸é Ç³Å亴À̶ó´Â ¿ë¾î°¡ ÀûÀýÇÏ´Ù. ±¹³»ÀûÀ¸·Î´Â ÂêÂê°¡¹«½Ãº´, ¾ß»ýÅä³¢º´, ·¾Å佺ÇǶóÁõ µîÀÌ ¾Ë·ÁÁ® ÀÖ°í, ¼¼°èÀûÀ¸·Î´Â ¸»¶ó¸®¾Æ, È²¿­, ÆäÆ®½º, ÀϺ»ÁÖÇ÷ÈíÃæÁõ µîÀÌ ¾Ë·ÁÁ® ÀÖ´Ù.
¿µ¹® Hodgkin's disease ÇÑ±Û È£ÁöŲº´
¼³¸í   
  ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÇÑ ÇüÅÂÀÌ´Ù. È£ÁöŲº´Àº ¹æ»ç¼± Ä¡·á¿¡ ´ë´ÜÈ÷ ¿¹¹ÎÇØ¼­ ÃæºÐÇÑ ¾çÀÇ ¹æ»ç¼±À¸·Î ¿ÏÀüÇÑ ±ÙÄ¡Àû Ä¡·á°¡ °¡´ÉÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • aluminium dust disease
    ¾Ë·ç¹Ì´½°¡·çº´
  • alveolar hydatid disease
    ²Ê¸®ÇüÆ÷Ãæº´, ´Ù¹æÆ÷Ãæº´
  • Alzheimer disease
    ¾ËÃ÷ÇÏÀ̸Ӻ´
  • Andersen¡¯s disease
    ¾Èµ¥¸£¼¾º´
  • anemia of chronic disease
    ¸¸¼ºº´ºóÇ÷
  • Batten¡¯s disease
    ¹èưº´
  • bauxite fume disease
    º¸Å©»çÀÌÆ®Áõ±âº´
  • Behcet¡¯s disease
    º£ÈåüƮº´
  • Binswanger disease
    ºó½º¹æ°Åº´
  • bird fancier¡¯s disease
    Á¶·ù»çÀ°ÀÚº´
  • bleeder¡¯s disease
    Ç÷¿ìº´, ÃâÇ÷¼ºÈ¯ÀÚº´
  • blue disease
    û»öº´
  • Bowen¡¯s disease
    º¸¿£º´
  • Buerger¡¯s disease
    ¹ö°Åº´
  • climatic disease
    ±âÈĺ´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • adult disease
    ¼ºÀκ´
  • aircraft disease
    (¢¡aviator's disease) Ç×°øº´
  • alkali disease
    ¾ËÄ®¸®º´
  • allergic disease
    ¾Ë·¹¸£±âº´
  • aluminium dust disease
    ¾Ë·ç¹Ì´½°¡·çº´
  • alveoar hydatid disease
    ²Ê¸®ÇüÆ÷Ãæº´, ´Ù¹æÆ÷Ãæº´
  • arteriosclerotic cardiovascular disease
    µ¿¸Æ°æÈ­½ÉÀåÇ÷°üº´
  • arteriosclerotic heart disease
    µ¿¸Æ°æÈ­½ÉÀ庴
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½ºº´
  • atherosclerotic heart disease
    Á×»ó°æÈ­½ÉÀ庴
  • autoallergic disease
    ÀÚ°¡¾Ë·¹¸£±âº´
  • autoimmune disease
    ÀÚ°¡¸é¿ªº´
  • autoimmune inner ear disease
    ÀÚ°¡¸é¿ª¼Ó±Íº´
  • aviator¡¯s disease
    Ç×°øº´
  • bacterial disease
    ¼¼±Õº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
  • hypersensitivity, delayed-type
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • hypersensitivity, immediate-type
    Áï½ÃÇü °ú¹Î¹ÝÀÀ
  • hypertrophic type
    ºñ´ëÇü
  • hypogammaglobulinemia, Swiss-type
    ½ºÀ§½ºÇü °¨¸¶±Û·ÎºÒ¸°ÀúÇ÷Áõ
  • personality disorder, mixed type
    È¥ÀçÇü(ûèî¤úþ) ÀΰÝÀå¾Ö
  • personality, type A
    AÇü ÀΰÝ
  • personality, type B
    BÇü ÀΰÝ
  • phage type
    ÆÄÁöÇü(¡­úþ).
  • phage type
    ÆÄÁöÇü
  • phased linear array type
    À§»óÂ÷ ¼±Çü ¹è¿­½Ä
  • phased linear array type
    À§»óÂ÷ ¹è¿­½Ä ¼±Çü (êÈßÓó¬ ÛÕÖªãÒ àÊû¡) Æ®·£½ºµà¼­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • calcified hypertrophic type
    ¼®È¸È­ºñ´ëÇü
  • catatonic type
    ±äÀåÇü
  • cellular type dermatofibroma
    ¼¼Æ÷Çü ÇǺμ¶À¯Á¾
  • chief cell type i glomus cell
    °ú¸³¼¼Æ÷
  • cryptogenic type
    ÀáÀçÇü(ËöËøÌ´).
  • cryptogenic type
    ÀáÀçÇü(íÖî¤úþ).
  • crystal type
    °áÁ¤Çü
  • culture, type
    Ç¥ÁرÕÁÖ, ±âÁØÁÖ
  • cyclicodevelopmental type
    ÁÖ±âÀû ¹ßÀ°Çü(ÊÙËÑËôÌ´).
  • cyclicopropagative type
    ÁÖ±âÀû Áõ½ÄÇü(ÊÙÌ¡ËàÌ´).
  • delayed type hypersensitivity
  • delayed-type hypersensitivity
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • demand type pacemaker
    ¼ö¿äÇü½É¹ÚÁ¶À²±â.
  • demblee type mycosis fungoides
    Àü°ÝÇü±Õ»ó½ÄÀ°Á¾
  • dementia of Alzheimers type
    ¾ËÃ÷ÇÏÀ̸ÓÇü Ä¡¸Å(~û¡ ö¸Å)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Refsum's disease
    ·¾¼û Áúȯ(òðü´)
  • Sandhoff's disease
    ¼¾µµÇÁ Áúȯ(òðü´)
  • sickle cell disease
    ³´¼¼Æ÷(á¬øà)Áúȯ(òðü´)
  • Tangier disease
    źÁö¿¡¸£ Áúȯ(òðü´)
  • Tay-Sachs disease
    ŸÀÌ-»è½º Áúȯ(òðü´)
  • von Gierke's disease
    Æù ±â¿¡¸£ÄÉ Áúȯ (òðü´)
  • von Willebrand's disease
    Æù ºô·¹ºê¶õÆ® Áúȯ (òðü´)
  • Wilson's disease
    Àª½¼ Áúȯ (òðü´)
  • Wolman's disease
    ¿ï¸¸ Áúȯ (òðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • valvular heart disease
    ÆÇ¸·¼º½ÉÁúȯ
  • wasting disease
    ¼Ò¸ðº´
  • Wilson's disease
    Àª½¼º´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
AHD acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;...
ARD absolute reaction of degeneration; acute radiation disease; acute respiratory disease; adult respira...
DD dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional...
DDD AV universal [pacemaker]; defined daily dose; degenerative disc disease; dehydroxydinaphthyl disulfi...
ND Doctor of Naturopathy; nasal deformity; natural death; Naval Dispensary; neonatal death; neoplastic ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
JH III Juvenile hormone III
pol III Polymerase III
P-III-P precollagen-III-peptide
PDE III phosphodiesterase III
URO-III-S uroporphyrinogen III synthase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • split electrode type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ
  • sympathicotonic type
    ±³°¨½Å°æ ±äÀåÇü
  • target type
    ¸ñÇ¥¹° ÇüÅÂ
  • type A personality
    AÇü Àμº
  • type B personality
    BÇü Àμº
  • type cultural
    ´ëÇ¥ ±ÕÁ¾ ¹è¾ç, Ç¥ÁØ ¹è¾ç
  • type II
    2Çü
  • type of eruption
    ¸ÍÃâÇü
  • type strain
    ´ëÇ¥ ±ÕÁ¾, Ç¥ÁØ ±ÕÁ¾
  • undulant type
    ÆÄ»óÇü
    ÆÄ»ó º¯µ¿À» Ư¡À¸·Î ÇÏ´Â Çü.
  • water in oil type
    À¯Áß¼öÀûÇü
  • Widman type flap
    WidmanÇü ÇÇÆÇ
  • wild type
    ¾ß»ýÇü
  • XY-type
    ¿¢½º¿ÍÀÌ Çü
    ¾Ï¼ö ¾î´À ÇÑÂÊÀÇ ¼º ¿°»öü Áß 1°³°¡ ´Ù¸¥ ¼º ¿°»öü¿Í Çü»óÀ» ´Þ¸®ÇÏ´Â »óÅ·μ­ ¼ºÀÌ °áÁ¤µÇ´Â °ÍÀ¸·Î, ÀÌ »ý¹°À» XY ÇüÀÇ »ý¹°À̶ó°í Çϸç, ¼öÄÆÀÌ ÀÌÇüÀÎ XYÇü , ¾ÏÄÆÀÌ ÀÌÇüÀÎ ZWÇüÀ¸·Î ±¸º°Çϱ⵵ ÇÑ´Ù.
  • Acosta's disease
    ¾ÆÄÚ½ºÅ¸º´
    µ¿ÀǾî=acute mountain sickness.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
mucolipidosis III <biochemistry> Mucolipidosis with mild Hurler-like symptoms, restricted joint mobility, short stature, mild mental retardation, and dysplastic skeletal changes, especially of the hip. Aortic and mitral valve disease are often present.
It is associated with a deficiency of UDP-N-acetyl glucosamine and lysosomal enzyme N-acetylglucosaminyl-1-phosphotransferase.
Inheritance: autosomal recessive.
Synonym: pseudo-Hurler polydystrophy, pseudopolydystrophy.
(05 Mar 2000)
mucopolysaccharidosis III Mucopolysaccharidosis characterised by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.
(12 Dec 1998)
congenital antithrombin III deficiency Antithrombin III is a protein which stimulates the removal of blood clots in the bloodstream. Small blood clots form normally within the bloodstream, but are normally dissolved via the bodys antithrombin III. The deficiency of antithrombin III will result in an increased risk for blood clot formation causing organ damage. This is an inherited as a autosomal dominant trait.
Inheritance: autosomal dominant.
(27 Sep 1997)
connective tissue activating peptide III Cytokine, produced from platelet basic protein, that acts as a growth factor.
(18 Nov 1997)
mycinamicin III O-methyltransferase <enzyme> Catalyses the incorporation of the methyl group of s-adenosyl-l-methionine at the 3'' position of mycinamicin III; from micromonospora griseorubida; genbank d16097
Registry number: EC 2.1.1.-
Synonym: mycf gene product, miii o-mtase
(26 Jun 1999)
cranial mononeuropathy III (compression type) A disorder involving vision changes and eyelid drooping associated with a decreased functioning of cranial nerve III. Damage is usually caused by compression of the nerves from localised lesions or a swelling in the area of the nerve.
Examples include cerebral aneurysms and tumours Symptoms include a drooping eyelid and double vision.
(diabetic type) A disorder involving vision changes and eyelid drooping associated with a decreased functioning of cranial nerve III as a complication of diabetes.
Symptoms include a drooping eyelid and double vision. Good control of blood sugars can reduce the incidence of this complication.
(27 Sep 1997)
cranial nerve III <anatomy, nerve> The occulomotor nerve is responsible for motor enervation of upper eyelid muscle, extraocular muscle and pupillary muscle.
Lesions of the oculomotor nerve results in ptosis (dropping eyelid), deviation of the eyeball outward, double vision and a dilated pupil.
Synonym: cranial nerve III.
(27 Sep 1997)
processus styloideus ossis metacarpalis III A pointed projection from the dorsolateral angle of the base of the third metacarpal bone; it sometimes exists as a separate ossicle.
Synonym: processus styloideus ossis metacarpalis III.
(05 Mar 2000)
Hind III <enzyme, molecular biology> Commonly used type II restriction endonuclease isolated from Haemophilus influenzae, it cleaves the sequence AAGCTT between the two As thus generating sticky ends.
(18 Nov 1997)
HTLV-III <abbreviation> Human T-cell lymphotropic virus type III.
See: human immunodeficiency virus.
(05 Mar 2000)
NADH-Fe(III)EDTA oxidoreductase <enzyme> From cryptococcus albidus; catalyses the formation of nad+ and fe(ii)edta from NADH and fe(iii)edta; forms ethylene from 2-oxo-4-methylthiobutyric acid
Registry number: EC 1.6.99.-
(26 Jun 1999)
Sudan III A red stain, (C6H5)N==N(C6H4)N==N(C10H6)OH, used for neutral fat in histologic technique; it also stains the fatty envelope of the tubercle bacillus.
Synonym: Sudan red III.
(05 Mar 2000)
Sudan red III A red stain, (C6H5)N==N(C6H4)N==N(C10H6)OH, used for neutral fat in histologic technique; it also stains the fatty envelope of the tubercle bacillus.
Synonym: Sudan red III.
(05 Mar 2000)
DNA polymerase III <enzyme> An enzyme that aids in DNA replication. It has a number of different functions, such as: proofreading newly replicated DNA, removing nucleotides from the 3' end of the strand one by one, and binding nucleotides from the 5' end of the strand.
(09 Oct 1997)
ductus pharyngobranchialis III A narrow communication between the third branchial pouch and the pharynx in the embryo.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • potts disease
    Æ÷Æ®º´;ôÃß Ä«¸®¿¡½º
  • psychosomatic disease
    Á¤½Å ½Åü (½É½Å) Áõ
  • pullet disease
    X;=BLUE COMB
  • rat-bite fever(disease)
    ¼­±³¿­
  • rheumatic disease
    ·ù¸ÓƼ½º¼º Áúȯ
  • social disease
    ¼ºº´
  • stress disease
    (ÀÚ±Ø,±äÀåÀ¸·Î ÀϾ´Ù´Â) ½ºÆ®·¹½ºº´
  • vocational disease
    Á÷¾÷º´
  • zymotic disease
    ¹ßÈ¿º´;¹ßÈ¿°¡ º´ÀÎÀ¸·Î ¿©°ÜÁ³´øsmallpoxµûÀ§
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á